Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Xomed Inc.

Division of Medtronic PLC
www.xomed.com

Latest From Medtronic Xomed Inc.

Intersect Follows Leaders In ENT

Following the lead of ENT start-ups like Acclarent and Entellus Medical, Intersect ENT Inc. is introducing a line of stent like implants capable of performing the same role drug-eluting stents played in interventional cardiology. Intersect’s implants provide moderate structural support to tissue that has been cut or dilated through FESS or balloon sinuplasty. But the principal function of the implant isn’t propping open nasal passageways but rather delivering drugs. A trio of clinical studies conducted by the company has found the released steroids produced statistically significant reductions in inflammation, polyp formation, and postoperative adhesions.

Medical Device United States

Entellus: Helping The Interventional Revolution Balloon In Sinus Therapy

The second company in the US looking to replace certain sinus surgeries with interventional procedures, Entellus is looking to further advance this technology by moving treatment from the OR to the doctor's office.
Medical Device United States

Ethicon Buys Acclarent: Can This Exit Open Up ENT?

Traditionally, the ENT space has been a bit of a technology backwater in terms of device innovation. Indeed, it has been more than a decade since the last major ENT deal, which made Medtronic the sole major strategic player in the ENT space. That dynamic has now changed with J&J/Ethicon's acquisition of Acclarent. Now the question is whether this deal will help open up the ENT space to more M&A activity?
Medical Device Business Strategies

M&A In Medical Devices: A More Robust Climate? Yes & No

Over the last three years, deal values in medical device M&A have hit all time highs, with more big deals done than ever before. Still, even with deal values soaring, device M&A remains a small-stakes game. IN VIVO looks at dealmaking in medtech by therapeutic and industry segments.
Medical Device Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Otolaryngology > Meniere's Disease
  • Alias(es)
  • Xomed Surgical Products Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Medtronic PLC
  • Senior Management
  • Bob Blankemeyer, Pres.
    Dean Rustad, VP, Fin.
    Timothy J Kriewall, PhD, VP, R&D
  • Contact Info
  • Medtronic Xomed Inc.
    Phone: (904) 296-9600
    6743 Southpoint Dr. North
    Jacksonville, FL 32216-0980
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register